Hypercholesterolemia treatment

Hypercholesterolemia Microchapters
Home
Patient Info
Overview
Epidemiology and Demographics
Risk Factors
Screening
Pathophysiology & Etiology
Natural History, Complications & Prognosis
Associated Conditions
Diagnosis
History & Symptoms
Physical Examination
Lab Tests
MRI
CT
Ultrasound
Other Imaging Findings
Pathology
Other Diagnostic Studies
Treatment
NCEP Approach
Primary Prevention
Secondary Prevention
Secondary Targets
Hypercholesterolemia treatment On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypercholesterolemia treatment
CDC on Hypercholesterolemia treatment
Hypercholesterolemia treatment in the news
Blogs on Hypercholesterolemia treatment</small>
Directions to Hospitals Treating Hypercholesterolemia treatment
Risk calculators and risk factors for Hypercholesterolemia treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Kashish Goel, M.D.

Overview

Cholesterol is present in the body as 3 main forms: Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and very low density lipoprotein cholesterol (VLDL-C). Out of these forms, the primary target for risk reduction is LDL-C. National Cholesterol Education Program developed the Adult Treatment Panel III guidelines in 2001 (updated recommendations in 2004) to guide physicians about appropriate treatment of hypercholesterolemia.